Breaking Barriers: Innovative Fabrication Processes for Nanostructured Materials and Nano Devices
Kaushal Kumar,
No information about this author
Saurav Dixit,
No information about this author
Md. Zia ul Haq
No information about this author
et al.
E3S Web of Conferences,
Journal Year:
2023,
Volume and Issue:
430, P. 01197 - 01197
Published: Jan. 1, 2023
This
study
explores
the
world
of
nanostructured
materials
and
new
production
procedures,
revealing
how
they
interact
to
break
down
obstacles
in
research.
We
uncover
confluence
between
theoretical
goals
actual
reality
by
investigating
manufacturing
processes.
The
links
processes
material
characteristics,
establishing
groundwork
for
informed
applications
electronics,
photonics,
sensors,
biology.
empirical
journey
illuminates
problems
opportunities,
prompting
joint
efforts
push
these
frontiers
forward.
article
is
a
testimony
materials'
transformational
potential,
challenging
researchers
dreamers
redefine
technological
landscapes
using
their
unique
features
inventive
production.
Language: Английский
Nanoparticles derived from herbal preparations May represent a novel nucleic acid therapy
Deleted Journal,
Journal Year:
2024,
Volume and Issue:
2(2)
Published: Feb. 2, 2024
Abstract
A
significant
number
of
nucleic
acid
therapies
have
been
approved,
highlighting
the
vast
potential
therapeutics.
Although
numerous
delivery
strategies
investigated,
and
progress
has
made
in
systems,
oral
route
still
presents
a
obstacle.
Recently,
novel
promising
force
emerged,
namely
Decoctosomes
Bencaosomes,
obtained
from
decoction
natural
herbs,
which
refers
to
boiled
Chinese
herbal
medicines.
The
active
components
include
small
molecules,
peptides,
RNAs
(sRNAs).
sRNAs
were
first
targets
extensive
research.
Additionally,
Bencaosomes
proven
effective
several
disease
mouse
models
as
artificially
enhanced
decoctosome
products.
This
perspective
summarizes
development
possible
future
directions
two
varieties
nanoparticles
that
may
open
door
new
possibilities
therapy.
Language: Английский
RNA-based therapies in liver metabolic diseases
Gut,
Journal Year:
2025,
Volume and Issue:
unknown, P. gutjnl - 331742
Published: Feb. 23, 2025
RNA-based
therapeutics
have
rapidly
emerged
over
the
past
decade,
offering
a
new
class
of
medicines
that
differ
significantly
from
conventional
drugs.
These
therapies
can
be
programmed
to
target
or
restore
defective
genes,
allowing
for
more
personalised
treatments
and
reducing
side
effects.
Notably,
RNA
made
significant
progress
in
treatment
genetic
liver
diseases,
exemplified
by
small
interfering
hereditary
transthyretin
amyloidosis,
which
use
liver-targeting
strategies
such
as
GalNAc
conjugation
improve
efficacy
safety.
gene-editing
technologies,
base
editor
prime
clustered
regularly
interspaced
short
palindromic
repeats
systems,
also
show
promise
with
their
ability
minimise
genomic
rearrangements
cancer
risk.
While
offer
high
precision,
challenges
remain
optimising
delivery
methods
ensuring
long-term
safety
efficacy.
Lipid
nanoparticle-mRNA
therapeutics,
particularly
protein
replacement
rare
gained
support
preclinical
successes.
Compared
viral
gene
therapies,
mRNA
present
safer
profile
reduced
risks
integration
oncogene
activation.
However,
clinical
trials,
especially
face
limitations
sample
sizes
observation
periods.
Further
studies,
including
non-human
primates,
will
essential
refining
trial
designs.
Despite
potential,
costs
pose
challenge
require
cost–utility
models
guide
pricing
accessibility.
Here,
we
discuss
fundamental
aspects
showcase
most
relevant
developments
metabolic
diseases.
Language: Английский
Evaluation of Pharmacokinetics, Immunogenicity, and Immunotoxicity of DNA Tetrahedral and DNA Polymeric Nanostructures
Small Methods,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 6, 2024
Abstract
Deoxyribonucleic
acid
(DNA)
nanostructures
have
been
extensively
explored
in
biomedical
applications
and
emerged
as
a
promising
platform
for
drug
delivery,
bioanalysis,
therapeutics.
Their
vivo
behaviors
received
much
attention,
prerequisite
clinical
applications.
Herein,
the
pharmacokinetics,
immunogenicity,
immunotoxicity
of
two
representative
DNA
nanostructures:
tetrahedron
(TDN)
nanoparticle
(DNP)
are
studied.
The
pharmacokinetics
monitored
mouse
model
via
tracking
32
P
radiolabeled,
half‐lives
TDN
DNP
9.88
19.80
min,
respectively.
preferentially
accumulate
liver
kidney
one
half‐life
metabolized
through
liver,
kidney,
excreta
after
24
h.
Meanwhile,
elicit
weak
pro‐inflammatory
immune
response
with
low
immunogenicity
non‐immunotoxic,
shown
by
evaluation,
histopathology,
serum
biochemical
index
analysis.
This
research
shows
that
safe
biological
systems,
indicating
can
be
developed
therapeutic
platforms
biomedicine.
Language: Английский
In Vivo Interactions of Nucleic Acid Nanostructures With Cells
Yu Xiao,
No information about this author
Zhihui Liang,
No information about this author
Moldir Shyngys
No information about this author
et al.
Advanced Materials,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 12, 2024
Abstract
Nucleic
acid
nanostructures,
derived
from
the
assembly
of
nucleic
building
blocks
(e.g.,
plasmids
and
oligonucleotides),
are
important
intracellular
carriers
therapeutic
cargoes
widely
utilized
in
preclinical
nanomedicine
applications,
yet
their
clinical
translation
remains
scarce.
In
era
“translational
nanotechnology”,
a
deeper
mechanistic
understanding
interactions
nanostructures
with
cells
vivo
will
guide
development
more
efficacious
nanomedicines.
This
review
showcases
recent
progress
dissecting
four
key
types
(i.e.,
tile‐based,
origami,
spherical
acid,
nanogel)
rodents
over
past
five
years.
Emphasis
lies
on
cellular‐level
distribution
various
organs
tissues
cellular
responses
induced
by
entry.
Next,
spirit
translation,
this
features
latest
large
animals
humans.
Finally,
offers
directions
for
studying
both
materials
biology
perspectives
concludes
some
regulatory
updates.
Language: Английский
Functionalities of pH-responsive DNA nanostructures in tumor-targeted strategies
Journal of Materials Chemistry B,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Jan. 1, 2024
Nanostructures
integrating
pH-sensitive
DNA
motifs
have
emerged
as
versatile
platforms
for
active
tumor
targeting,
owing
to
their
ability
undergo
conformation
changes
in
response
the
common
acidic
environment
of
extracellular
matrix
and
endocytosis
pathway.
This
review
summarizes
latest
advances
design
application
various
pH-responsive
nanostructures
tumor-targeted
strategies,
including
recognition,
cell
imaging,
dynamic
nanocarrier
construction,
controlled
drug
release.
A
comprehensive
framework
pH-controlled
multi-stage
targeting
is
introduced,
addressing
divergences
strategies
intracellular
environments.
The
unique
attributes,
practical
performance
challenges
are
also
critically
discussed
provide
guidance
future
development
this
field.
Language: Английский
High‐Throughput, Label‐Free Detection of DNA Origami in Single‐Cell Suspensions Using origamiFISH‐Flow
Shana Alexander,
No information about this author
Wendy Xueyi Wang,
No information about this author
Chung‐Yi Tseng
No information about this author
et al.
Small,
Journal Year:
2024,
Volume and Issue:
20(35)
Published: April 30, 2024
Structural
DNA
nanotechnology
enables
custom
fabrication
of
nanoscale
devices
and
promises
diverse
biological
applications.
However,
the
effects
design
on
nanostructure
(DN)-cell
interactions
in
vitro
vivo
are
not
yet
well-characterized.
origamiFISH
is
a
recently
developed
technique
for
imaging
DNs
cells
tissues.
Compared
to
use
fluorescent
tags,
offers
label-free
structure-agnostic
detection
with
significantly
improved
sensitivity.
Here,
extended
quantify
single-cell
suspensions,
including
nonadherent
such
as
subsets
immune
cells,
via
readout
by
flow
cytometry.
This
method,
referred
origamiFISH-Flow,
high-throughput
(e.g.,
10
000
per
second)
compatible
immunostaining
concurrent
cell-type
cell-state
characterization.
It
shown
that
origamiFISH-Flow
provides
20-fold
higher
signal-to-noise
ratio
DN
compared
dye
labeling
approaches,
leading
capture
>25-fold
more
Language: Английский
Analysis of Nanoparticles’ Effects on Drug-Induced Psoriasis
Methods in molecular biology,
Journal Year:
2024,
Volume and Issue:
unknown, P. 129 - 135
Published: Jan. 1, 2024
Language: Английский
Emerging Voices in Drug Delivery – Harnessing and Modulating Complex Biological Systems (Issue 2)
Advanced Drug Delivery Reviews,
Journal Year:
2024,
Volume and Issue:
208, P. 115293 - 115293
Published: March 21, 2024
Language: Английский
High-throughput, label-free detection of DNA origami in single-cell suspensions using origamiFISH-Flow
Shana Alexander,
No information about this author
Wendy Xueyi Wang,
No information about this author
Chung‐Yi Tseng
No information about this author
et al.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Nov. 2, 2023
Abstract
Structural
DNA
nanotechnology
enables
custom
fabrication
of
nanoscale
devices
and
promises
diverse
biological
applications.
However,
the
effects
design
on
nanostructure
(DN)-cell
interactions
in
vitro
vivo
are
not
yet
well-characterized.
origamiFISH
is
a
recently
developed
technique
for
imaging
DNs
cells
tissues.
Compared
to
use
fluorescent
tags,
offers
label-free
structure-agnostic
detection
with
significantly
improved
sensitivity.
Here,
we
extend
quantifying
single-cell
suspensions,
including
nonadherent
such
as
subsets
immune
cells,
via
readout
by
flow
cytometry.
This
method,
referred
origamiFISH-Flow,
high-throughput
(e.g.,
10,000
per
second)
compatible
immunostaining
concurrent
cell-type
-state
characterization.
We
demonstrate
that
origamiFISH-Flow
enhances
signal-to-noise
ratio
up
20-fold
compared
dye
labeling
approaches,
leading
capture
>25-fold
more
DN
+
at
low,
single-picomolar
uptake
concentrations.
additionally
show
profile
shape-specific
patterns
across
cell
lines
splenocytes
quantify
accumulation
lymphoid
organs.
Together,
new
tool
interrogate
tissues,
while
providing
insights
tailoring
their
designs
bio-applications.
Language: Английский